|
|
|
Terrapinn Ltd, Palais des Congrès de Lyon
5-8 October 2009
World Vaccine Congress Lyon 2009 is not only Europe’s leading vaccine conference. It is a global knowledge experience, business meeting and access vehicle to your marketplace. Representation from key European Commission and regulatory agencies DG Research, DG SANCO, ECDC, EDQM, CHMP, VWP, MHRA, PEI, FAMHP and MEB provide vision and clarity on future industry progress and opportunities Europe’s largest commercial vaccine industry congress for decision makers across European and North America regions Including World class multiple speaker representation from Baxter, GSK Biologicals, MedImmune, Novartis Vaccines and Diagnostics, Pfizer, sanofi pasteur, sanofi Pasteur MSD, Solvay and Wyeth Vaccines Critical market opportunities outlined in billion Euro vaccine market European policy frameworks, vaccine regulation and authorisation, vaccine R&D innovation and introduction, Influenza market sustainability, corporate growth strategies and funding sources Please visit the website for full programme and speaker details. http://www.terrapinn.com/2009/wvcl
|
|
|
|
|
|
Organized by:
|
|
Terrapinn |
|
Invited Speakers:
|
|
2009 key speakers include: - Dr Ole Olesen, Scientific Officer, Neglected Infectious Diseases,Infectious Diseases Unit,DG-Research, European Commission
- Dr Pierluigi Lopalco, Senior Expert,Scientific Advice Unit, European Centre for Disease Prevention and Control
- Didier Hoch, President, sanofi pasteur MSD and Former President, European Vaccine Manufacturers
- Dr Philippe Dro, Chief Executive Officer, GlycoVaxyn
- Dr Matthias Schroff, Chief Executive Officer, Mologen
- Dr Luc Hessel, Executive Director, Medical and Public Affairs, Europe, sanofi pasteur MSD
- Dr Joe Cohen, Vice President R&D, Head of Vaccines for Emerging Diseases and HIV, GSK Biologicals
- Dr Jeffrey Ulmer, Global Head of External Research, Novartis Vaccines and Diagnostics
- Dr Hartmut Ehrlich, Vice President, Global Research and Development, Baxter BioScience
- Dr Jeff Southerton, Executive Director, Worldwide Business Development, Pfizer Global R&D
- Dr Bram Palache, Global Scientific Communication and Public Affairs Director for Influenza Vaccines, Solvay Biologicals
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2009-06-01
|
|
|
|
|
|
Registration:
|
|
Please visit the website for full details. http://www.terrapinn.com/2009/wvcl
|
|
E-mail:
|
|
paul.gilbertson@terrapinn.com
|
|
|
|
|
|
|
|